NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,230 | -23.5% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $1,607 | -7.7% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,741 | +88.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $924 | -7.6% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $3,000 | -40.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 100 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +14.3% | 200 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |